Eli Lilly’s New Weight-Loss Treatment Shows Promising Results
RSS SUMMARY · AGGREGATED FROM TWSJ
An investigational drug developed by Eli Lilly delivered clinically meaningful weight loss in a trial, the company said as it looks expand its obesity treatment portfolio amid soaring demand.
An investigational drug developed by Eli Lilly delivered clinically meaningful weight loss in a trial, the company said as it looks expand its obesity treatment portfolio amid soaring demand.
An investigational drug developed by Eli Lilly delivered clinically meaningful weight loss in a trial, the company said as it looks expand its obesity treatment portfolio amid soaring demand.
Continue Reading
The full story continues on The Wall Street Journal.
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.
The Source
TWSJ
Business
Flesh-Eating Screwworm Found in Texas Calf, USDA Says
TWSJ·1h ago·3 min read
World News
The Hormuz Squeeze Is Redrawing the Oil Map for Good
TWSJ·1h ago·3 min read
Tech
Meta Keeps Delaying the Release of Its New AI Model to Developers
TWSJ·1h ago·3 min read
Tech
Top AI CEOs Call for Law Protecting Against Biological Weapons
TWSJ·3h ago·3 min read
Related
On this beat
Health
An Uncertain Path for Americans Exposed to Ebola
TNYT·8h ago·3 min read
Health
Autism therapy has attracted predatory providers who bill for phantom services, pad hours and charge steep fees for care delivered by low-paid workers. Here are five takeaways from a WSJ investigation
TWSJ·12h ago·3 min read
Health
New research could help doctors tweak anesthesia to more resemble natural sleep, reducing risks
TWSJ·12h ago·3 min read
Health
Diets high in ultraprocessed foods are associated with an increased risk of dementia, a new study says, adding to the list of health problems linked to foods such as cookies, hot dogs and pizza
TWSJ·19h ago·3 min read